Loading...
XHKG0546
Market cap1.72bUSD
Dec 23, Last price  
5.29HKD
1D
0.95%
1Q
17.29%
Jan 2017
38.85%
IPO
86.27%
Name

Fufeng Group Ltd

Chart & Performance

D1W1MN
XHKG:0546 chart
P/E
3.99
P/S
0.45
EPS
1.25
Div Yield, %
9.63%
Shrs. gr., 5y
-0.10%
Rev. gr., 5y
15.27%
Revenues
28.01b
+1.94%
1,787,247,0002,445,652,0003,585,343,0004,632,884,0006,416,425,0008,399,246,00011,111,920,00011,366,722,00011,297,696,00011,225,722,00011,803,131,00013,033,501,00013,764,645,00016,170,850,00016,690,736,00021,539,841,00027,474,639,00028,006,875,000
Net income
3.14b
-18.57%
240,483,00045,069,000294,706,000928,285,000966,051,000604,137,000426,553,000506,132,000626,428,000516,261,0001,092,512,0001,382,380,0001,845,039,0001,137,223,000629,901,0001,280,640,0003,861,078,0003,144,124,000
CFO
1.70b
-52.64%
183,981,000-38,078,000448,943,000586,174,0001,119,950,000248,248,000760,435,0001,038,529,0001,641,726,0001,148,638,0002,089,940,9991,202,209,0001,509,618,000892,160,000205,618,0002,774,430,0003,600,102,0001,704,877,000
Dividend
Sep 10, 20240.16 HKD/sh
Earnings
Mar 25, 2025

Profile

Fufeng Group Limited, an investment holding company, engages in the manufacture and sale of fermentation-based food additive, and biochemical and starch-based products in the People's Republic of China and internationally. It operates through Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and Other segments. The Food Additives segment manufactures and sells monosodium glutamate, starch sweeteners, glutamic acid, compound seasoning, and corn oil. The Animal Nutrition segment manufactures and sells corn refined products, threonine, and lysine. The High-End Amino Acid segment offers high-end amino acid products. The Colloid segment provides xanthan and gellan gum products. The Other segment offers fertilisers, synthetic ammonia, pharmaceuticals, and other products. It also engages in the manufacture and sale of autoclaved aerated concrete blocks, eubacteria material medicine, preparations and food additives, bricks, and other related products; research and development, promotion, and industrialization of new biological techniques and achievements; sale of cosmetics, biological products, and health food and other related products; and provision of logistics and equity investment services, as well as information services of biological techniques. Fufeng Group Limited was founded in 1999 and is based in Linyi, the People's Republic of China.
URL
https://www.fufeng-group.com/
IPO date
Feb 08, 2007
Employees
16,500
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
28,006,875
1.94%
27,474,639
27.55%
21,539,841
29.05%
Cost of revenue
25,140,290
23,441,878
20,361,920
Unusual Expense (Income)
NOPBT
2,866,585
4,032,761
1,177,921
NOPBT Margin
10.24%
14.68%
5.47%
Operating Taxes
706,121
999,231
235,334
Tax Rate
24.63%
24.78%
19.98%
NOPAT
2,160,464
3,033,530
942,587
Net income
3,144,124
-18.57%
3,861,078
201.50%
1,280,640
103.31%
Dividends
(1,284,246)
(1,079,216)
(292,653)
Dividend yield
11.64%
8.96%
4.29%
Proceeds from repurchase of equity
(42,760)
6,278,671
BB yield
0.39%
-52.14%
Debt
Debt current
9,577,992
5,459,465
1,723,028
Long-term debt
208,019
659,522
2,576,715
Deferred revenue
756,723
776,426
Other long-term liabilities
984,659
(848,373)
(793,076)
Net debt
6,943,875
(974,002)
700,119
Cash flow
Cash from operating activities
1,704,877
3,600,102
2,774,430
CAPEX
(2,161,270)
(988,121)
(497,903)
Cash from investing activities
(1,513,871)
(647,640)
(549,539)
Cash from financing activities
(436,594)
92,410
525,065
FCF
(7,002,715)
1,948,910
1,485,633
Balance
Cash
2,832,136
7,082,795
3,585,534
Long term investments
10,000
10,194
14,090
Excess cash
1,441,792
5,719,257
2,522,632
Stockholders' equity
17,100,739
15,572,857
12,769,175
Invested Capital
26,652,527
16,384,278
15,162,478
ROIC
10.04%
19.23%
6.14%
ROCE
10.20%
18.17%
6.65%
EV
Common stock shares outstanding
2,535,778
2,535,211
2,533,651
Price
4.35
-8.42%
4.75
76.58%
2.69
-8.81%
Market cap
11,030,634
-8.40%
12,042,252
76.69%
6,815,521
-8.81%
EV
17,974,509
11,413,768
7,866,495
EBITDA
3,990,120
5,186,454
2,416,650
EV/EBITDA
4.50
2.20
3.26
Interest
165,053
238,504
172,712
Interest/NOPBT
5.76%
5.91%
14.66%